| abstract |
The present invention relates to the treatment of psychiatric disorders and neurological disorders, anxiety-related disorders, post-traumatic stress disorder, nuclear paralysis and eating disorders, as well as immunological, cardiovascular or heart-related disorders, and colons due to psychopathological disorders and stress. Corticosteroid releasing factor (CRF) antagonists of formula (I) and their use in the treatment of hypersensitivity.n n n <Formula I> |